Concept Life Sciences Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Concept Life Sciences Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013127
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Concept Life Sciences Ltd (Concept Life Sciences), formerly Peakdale Molecular Ltd, a subsidiary of Concept Life Sciences Holdings Ltd is a provider of integrated discovery and development solution. The company services include integrated drug discovery and development services and analytical services. its analytical services include life sciences, food and consumer services, industrial and environmental services, chemicals and online reporting. The company caters its services to pharmaceutical, biotechnology, petrochemical, agrochemical, chemical and consumer products industries. It has operations across the UK. Concept Life Sciences is headquartered in Manchester, the UK.

Concept Life Sciences Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Concept Life Sciences Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Concept Life Sciences Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
Equistone Partners Europe Acquires Majority Interest in Concept Life Sciences 11
Partnerships 12
Aquila BioMedical Enters into Co-Development Agreement with Macrophage Pharma 12
Metrion Biosciences Enters into Agreement with Concept Life Sciences 13
Acquisition 14
Concept Life Sciences Acquires Aquila BioMedical 14
Concept Life Sciences Acquires CXR Biosciences 15
Concept Life Sciences Acquires Peakdale Molecular 16
Concept Life Sciences Acquires Scientific Analysis Laboratories 17
Concept Life Sciences Acquires Resource and Environmental Consultants 18
Concept Life Sciences Ltd – Key Competitors 19
Concept Life Sciences Ltd – Key Employees 20
Concept Life Sciences Ltd – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Strategy And Business Planning 22
Sep 12, 2017: Concept Life Sciences expands into Alderley Park to support discovery services growth 22
Corporate Communications 23
Oct 24, 2017: Concept Life Sciences appoints Philip Payne as Chief Commercial Officer 23
Apr 03, 2017: Concept Life Sciences Further Strengthens Its Senior Team 24
Other Significant Developments 25
Mar 01, 2017: Concept Life Sciences Group Announces Multi-Million Pound Expansion Programme And Rebranding 25
Jun 14, 2016: Concept Life Sciences Groups Expands Its Services to the US 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Concept Life Sciences Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Concept Life Sciences Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Concept Life Sciences Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Equistone Partners Europe Acquires Majority Interest in Concept Life Sciences 11
Aquila BioMedical Enters into Co-Development Agreement with Macrophage Pharma 12
Metrion Biosciences Enters into Agreement with Concept Life Sciences 13
Concept Life Sciences Acquires Aquila BioMedical 14
Concept Life Sciences Acquires CXR Biosciences 15
Concept Life Sciences Acquires Peakdale Molecular 16
Concept Life Sciences Acquires Scientific Analysis Laboratories 17
Concept Life Sciences Acquires Resource and Environmental Consultants 18
Concept Life Sciences Ltd, Key Competitors 19
Concept Life Sciences Ltd, Key Employees 20
Concept Life Sciences Ltd, Other Locations 21
Concept Life Sciences Ltd, Subsidiaries 21

★海外企業調査レポート[Concept Life Sciences Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Volt Information Sciences Inc (VOLT):企業の財務・戦略的SWOT分析
    Volt Information Sciences Inc (VOLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • FLIR Systems Inc:企業の戦略・SWOT・財務情報
    FLIR Systems Inc - Strategy, SWOT and Corporate Finance Report Summary FLIR Systems Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Bioasis Technologies Inc (BTI):企業の財務・戦略的SWOT分析
    Summary Bioasis Technologies Inc (BTI) is a developer and commercialize of pharmaceutical products and diagnostic technologies for central nervous system diseases and disorders. The company’s transcend program describes the proprietary carrier, p97 to deliver therapeutics and imaging agents across t …
  • SELEX Galileo Inc.:企業の戦略・SWOT・財務情報
    SELEX Galileo Inc. - Strategy, SWOT and Corporate Finance Report Summary SELEX Galileo Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Covalon Technologies Ltd (COV):製品パイプライン分析
    Summary Covalon Technologies Ltd (Covalon) is a researcher, developer and commercialization of medical devices and healthcare technologies. The company offers advanced wound solutions, infection prevention products and perioperative care products. Covalon offers wound care products such as collagen …
  • BioView Ltd (BIOV)-医療機器分野:企業M&A・提携分析
    Summary BioView Ltd (BioView) is a medical device company that develops, manufactures and markets automated cell imaging and analysis solutions, which incorporate proprietary imaging, analysis and review technology. The technology provides automatic control of fully motorized fluorescent and bright- …
  • Adams Resources & Energy Inc (AE):企業の財務・戦略的SWOT分析
    Adams Resources & Energy Inc (AE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Telos Corporation:企業の戦略・SWOT・財務情報
    Telos Corporation - Strategy, SWOT and Corporate Finance Report Summary Telos Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • MAX Resource Corp. (MXR):企業の財務・戦略的SWOT分析
    MAX Resource Corp. (MXR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Altana AG:企業の戦略的SWOT分析
    Altana AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • M1 Ltd (B2F):企業の財務・戦略的SWOT分析
    M1 Ltd (B2F) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Elekeiroz SA (ELEK3):企業の財務・戦略的SWOT分析
    Elekeiroz SA (ELEK3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • The Kingsbury Plc:企業の戦略・SWOT・財務情報
    The Kingsbury Plc - Strategy, SWOT and Corporate Finance Report Summary The Kingsbury Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • DPL Inc. (DPL):電力:M&Aディール及び事業提携情報
    Summary DPL Inc. (DPL) a subsidiary of AES Corporation is a diversified energy and utility company. It is engaged in the generation, transmission and distribution of electricity in West Central Ohio. The company provides its services to residential, commercial, and industrial and government customer …
  • Bruker Daltonics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Bruker Daltonics Inc (Bruker Daltonics), a subsidiary of Bruker Corp, is a medical device company that manufactures scientific instruments for molecular and materials research, and for industrial and applied analysis. The company's products include mass spectrometry and separations, preclini …
  • Katara Hospitality:企業の戦略・SWOT・財務情報
    Katara Hospitality - Strategy, SWOT and Corporate Finance Report Summary Katara Hospitality - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • McConnell Dowell Corp Ltd:企業の戦略的SWOT分析
    McConnell Dowell Corp Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Network Rail Ltd:企業の戦略的SWOT分析
    Network Rail Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • China Cinda Asset Management Co Ltd:企業のM&A・事業提携・投資動向
    China Cinda Asset Management Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China Cinda Asset Management Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on …
  • The Medicines Company (MDCO):製薬・医療:M&Aディール及び事業提携情報
    Summary The Medicines Company (TMC) is a biopharmaceutical company, which provides medical solutions for improving health conditions in patients under critical care. The company’s product portfolio comprises marketed products a peptide compound that inhibits an intravenous direct thrombin and needle …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆